Prescription Drugs
Filters
赫赛莱 恩美曲妥珠单抗（T-DM1）100/160mg | 罗氏中国原研 | GLT
获 NMPA 批准的罗氏赫赛莱（恩美曲妥珠单抗，T-DM1）100mg 及 160mg 瓶装，中国原研、靶向 HER2 的抗体偶联药物（ADC）。
Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche EU Originator | GLT
EMA-approved Roche Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, EU originator HER2-targeted ADC.
Saiweike (Pazopanib) 200mg*30 | Chia Tai Tianqing China Generic | GLT
Nanjing Chia Tai Tianqing — pazopanib 200mg generic for renal cell carcinoma & soft tissue...
Dipaite (Pazopanib) 200mg*30 | Acebright China Generic | GLT
Shanghai Acebright — pazopanib 200mg generic for renal cell carcinoma & soft tissue sarcoma
Wanxiwei (Pazopanib) 200mg*30 | Loncom China Generic | GLT
Shandong Loncom — pazopanib 200mg generic for renal cell carcinoma & soft tissue sarcoma
Pivikto (Alpelisib) 150mg 28 Tablets | Novartis India Original | GLT
Pivikto — Novartis India's original alpelisib brand, the most affordable genuine original for PIK3CA-mutated breast...
Piqray (Alpelisib) 150mg 56 Tablets | Novartis Hong Kong Original | GLT
Piqray Hong Kong original — 56 tablets = one 28-day treatment month, Novartis, approved in...
Piqray (Alpelisib) 150mg/200mg Tablets | Novartis Germany Original | GLT
Piqray — the Novartis original PI3Kα inhibitor for PIK3CA-mutated HR+/HER2- breast cancer, German original cartons
排序
- 推荐
- 价格由低到高
- 价格由高到底
- 最新
- 销量最高